Visit our Virtual Process Space for an interactive demonstration!

Mail icon

ChargePoint Technology Invests in Large Containment Valve Production Capabilities

5 July, 2017 | ChargePoint Technology

ChargePoint Technology has today announced its investment in new manufacturing machinery at its UK facility to enable it to meet the increase in demand for larger diameter valves for large scale, high containment drug manufacturing.

The new 5-axis machine is the first of its kind in the UK and forms part of a wider £1million investment into advanced manufacturing capabilities at ChargPoint’s HQ facility in Liverpool. It will enable us to speed up the production and delivery of larger diameter valves up to 350mm (14”).

The investment has been made in response to growing containment demands that are being driven by growth within therapeutic areas, including oncology and hormonal drug products. This is leading to increased volumes of high potency active pharmaceutical ingredients (HPAPIs) being used in the production of tablets, capsules and other solid dosage forms.

Tony O’Sullivan, chief commercial officer (CCO) at ChargePoint, commented on the investment: “We are seeing an increase in demand from solid dose manufacturing companies, including big pharma firms and CMOs in the US and Europe, for large scale containment valve solutions.

“Our new machinery enables us to manufacture larger diameter valves, directly addressing this market need. In addition, our in-house manufacturing strategy provides us with absolute control over the quality of the final product so our customers can rest assured that they receive high-performing and reliable technology.

“Growth in the high-volume manufacture of generics, particularly in Asia, is also driving demand for larger containment valves, as there is a need to upgrade existing process equipment to safely replicate the production of higher potency off patent drugs, while ensuring drug quality and operator safety. We expect this segment to grow in the future as the pharmaceutical landscape evolves.”

As part of the investment, a new automated washing plant will be used to ensure effective and repeat cleaning of parts with higher throughput capacity, while a new 3-axis coordinate measuring machine (CMM) will also allow for high precision measurement and scanning of critical valve components in-house.

ChargePoint intends to invest further in manufacturing capabilities at its facility over the next three years. In particular, it plans to continue to evolve its product design using the latest manufacturing methods to provide further advancements in valve technology.

An integral part of a complete powder handling system, ChargePoint valves are independently performance tested to the ISPE SMEPAC guidelines. We work with select material handling solution partners across North America, Europe and increasingly Asia to ensure an integrated high containment handling process is successfully achieved.

View our application video showcasing our automated large volume transfer valve technology in pharmaceutical tablet production.